A detailed history of Compass Capital Management, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Compass Capital Management, Inc holds 487,347 shares of MRK stock, worth $47.9 Million. This represents 3.34% of its overall portfolio holdings.

Number of Shares
487,347
Previous 464,509 4.92%
Holding current value
$47.9 Million
Previous $52.7 Million 8.09%
% of portfolio
3.34%
Previous 3.52%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$96.31 - $114.76 $2.2 Million - $2.62 Million
22,838 Added 4.92%
487,347 $48.5 Million
Q3 2024

Oct 24, 2024

BUY
$111.15 - $128.97 $2.59 Million - $3 Million
23,290 Added 5.28%
464,509 $52.7 Million
Q2 2024

Jul 25, 2024

SELL
$123.8 - $132.96 $1.59 Million - $1.71 Million
-12,880 Reduced 2.84%
441,219 $54.6 Million
Q1 2024

Apr 29, 2024

BUY
$113.24 - $131.95 $678,534 - $790,644
5,992 Added 1.34%
454,099 $59.9 Million
Q4 2023

Feb 05, 2024

BUY
$100.18 - $109.02 $1.24 Million - $1.35 Million
12,400 Added 2.85%
448,107 $48.9 Million
Q3 2023

Oct 27, 2023

SELL
$102.95 - $114.33 $2.01 Million - $2.23 Million
-19,548 Reduced 4.29%
435,707 $44.9 Million
Q2 2023

Jul 31, 2023

BUY
$108.61 - $118.38 $1.39 Million - $1.52 Million
12,815 Added 2.9%
455,255 $52.5 Million
Q1 2023

May 01, 2023

BUY
$102.94 - $114.86 $45.5 Million - $50.8 Million
442,440 New
442,440 $47.1 Million
Q1 2020

Apr 24, 2020

SELL
$63.36 - $87.82 $255,847 - $354,617
-4,038 Closed
0 $0
Q4 2019

Jan 30, 2020

BUY
$77.58 - $87.54 $111,715 - $126,057
1,440 Added 55.43%
4,038 $367,000
Q3 2019

Oct 22, 2019

BUY
$76.08 - $82.93 $7,455 - $8,127
98 Added 3.92%
2,598 $219,000
Q2 2019

Jul 31, 2019

BUY
$69.84 - $81.59 $174,600 - $203,975
2,500 New
2,500 $210,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Compass Capital Management, Inc Portfolio

Follow Compass Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Compass Capital Management, Inc with notifications on news.